ConradReport.com
Search Česky Subscribe

Company · United States

ELEVANCE HEALTH, INC.

CIK 0001156039Reports under US GAAP

Key figures

Latest quarterly period from 1 Jul 2026 to 30 Sep 2026. Consolidated statements, US GAAP. Amounts in USD.

Revenue
USD 51.4bn
Operating profit
USD 1.3bn
Net profit or loss
USD 1.4bn
Total assets
USD 128bn
Equity
USD 44.7bn
Liabilities
USD 83.0bn
Cash
USD 10.3bn

Symfio computed the numbers from the company's financial statements. Each number can be traced back to the statement it comes from.

Timeline

What happened at the company according to public sources, newest first.

  1. Significant change in revenue

  2. New financial statements filed

  3. Significant change in revenue

  4. New financial statements filed

In brief

Where the data comes from

SEC EDGAR, whole market (USA) (opens in a new window)Financial statements, retrieved 22 Oct 2026.

Public registersOwners, statutory body, registered office and their changes over time.

Symfio calculationsMargins, ratios and year-on-year changes, computed in Symfio.

Published by Symfio

Symfio can build a profile like this one from your own accounts

“Catches what you would miss.”